По вашему запросу найдено документов: 130

Страница 1 из 13

ХИМИОТЕРАПИЯ ПРИ ЛЕЧЕНИИ ОПУХОЛЕЙ МОЛОЧНОЙ ЖЕЛЕЗЫ С ПРИМЕНЕНИЕМ ДОКАЗАТЕЛЬНОЙ МЕДИЦИНЫ
CHEMOTHERAPY IN THE TREATMENT OF BREAST TUMORS USING EVIDENCE-BASED MEDICINE
Сулейманова, Г.Ф., SULEYMANOVA, G.F. (2024)
CHEMOTHERAPY IN THE TREATMENT OF BREAST TUMORS USING EVIDENCE-BASED MEDICINE
Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
Larionova, Irina, Iamshchikov, Pavel, Kazakova, Anna, Rakina, Militsa, Menyalo, Maxim, Enikeeva, Kadriia, Rafikova, Guzel, Sharifyanova, Yuliya, Pavlov, Valentin, Villert, Alisa, Kolomiets, Larisa, Kzhyshkowska, Julia (2025)
-line treatment with platinum-based chemotherapy. At present, numerous clinical trials are being conducted
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Kristeleit, Rebecca, Lisyanskaya, Alla, Fedenko, Alexander, Dvorkin, Mikhail, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Oza, Amit M (2022)
(PARP) inhibitors to chemotherapy for the treatment of BRCA1-mutated or BRCA2-mutated ovarian carcinoma
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
Oza, Amit M, Lisyanskaya, Alla, Fedenko, Alexander, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Kristeleit, Rebecca (2025)
Background: In the ARIEL4 trial of rucaparib versus standard-of-care chemotherapy in patients
Phase I/II trial of local interstitial chemotherapy with arsenic trioxide in patients with newly diagnosed glioma
Han, Dayong, Teng, Lei, Wang, Xiaoxiong, Zhen, Yunbo, Chen, Xiaofeng, Yang, Mingchun, Gao, Ming, Yang, Guang, Han, Mingyang, Wang, Ligang, Xu, Jiajun, Li, Yue, Shumadalova, Alina, Zhao, Shiguang (2022)
and chemotherapy. Arsenic trioxide could inhibit various tumors. However, it is a challenge to evaluate
АДЪЮВАНТНОЕ ЛЕЧЕНИЕ РАКА ЖЕЛУДКА
ADJUVANT TREATMENT OF GASTRIC CANCER
Д. Т. Арыбжанов, D. T. Arybzhanov, И. Р. Рахматуллина, I. R. Rakhmatullina (Креативная хирургия и онкология, №4, 2017)
adjuvant chemotherapy
ОТКРЫТЫЕ ВОПРОСЫ СТАНДАРТНЫХ ПОДХОДОВ В ОНКОЛОГИИ
PENDING ISSUES OF STANDARD APPROACHES IN ONCOLOGY
ТРЯКИН, А.А., ФЕДЯНИН, М.Ю., ПОКАТАЕВ, И.А., ПЕТРОВСКИЙ, А.В., TRYAKIN, A.A., FEDYANIN, M.YU., POKATAEV, I.A., PETROVSKY, A.V. (2020)
CHEMOTHERAPY
Cerebrovascular disorders in patients with malignant tumors
Beylerli, Ozal, Talybov, Rustam, Musaev, Elmar (2024)
Chemotherapy
ПОЗДНИЕ ОСЛОЖНЕНИЯ ЛЕЧЕНИЯ БОЛЬНЫХ ГЕРМИНОГЕННЫМИ ОПУХОЛЯМИ
Late complications of the treatment of patients with germ cell tumors
ДАНИЕЛЯН, Д.Г., САЛИМОВА, А.А., БУЛАНОВ, А.А., ФЕДЯНИН, М.Ю., ТРЯКИН, А.А., DANIELYAN D.G., SALIMOVA A.A., BULANOV A.A., FEDYANIN M. YU., TRYAKIN A.A. (2020)
CHEMOTHERAPY
ВНУТРИАРТЕРИАЛЬНАЯ ХИМИОТЕРАПИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ
INTRA-ATERIAL CHEMOTHERAPY OF THE BREAST CANCER
Ш. Х. Ганцев, Shamil Kh. Gantsev, К. Р. Умарова, Umarova R. Umarova, Д. Т. Арыбжанов, Dauranbek T. Arybzhanov (Креативная хирургия и онкология, №3, 2017)
INTRA-ATERIAL CHEMOTHERAPY OF THE BREAST CANCER

Страница 1 из 13

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год